Crystalline modifications of N-alpha- (2,4,6-triisopropylphenylsulfonyl)-3-hydr oxyamidino- (L)-phenylalanine-4-ethoxycarbonylpipe razide and/or salts thereof

Details for Australian Patent Application No. 2005308977 (hide)

Owner Wilex AG

Inventors Lenz, Jana; Grunenberg, Alfons

Agent Davies Collison Cave

Pub. Number AU-B-2005308977

PCT Pub. Number WO2006/056448

Priority 10 2004 057 195.3 26.11.04 DE

Filing date 24 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 15 September 2011

International Classifications

C07D 295/185 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

Event Publications

17 May 2007 PCT application entered the National Phase

  PCT publication WO2006/056448 Priority application(s): WO2006/056448

15 September 2011 Application Accepted

  Published as AU-B-2005308977

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005308978-Copper melphalan and copper tegafur used as anti-tumoral agents

2005308973-Monitor for CPAP/ventilator apparatus